Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04068844 · ClinicalTrials.gov registry record · NA
Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction
A NA study of Heart Failure, Diastolic, sponsored by University of Texas Southwestern Medical Center.
- Active
- Registry status
- NA
- Development phase
- 93
- Enrollment target
- 1
- Study location
NCT04068844: Active NA study of Heart Failure, Diastolic, sponsored by University of Texas Southwestern Medical Center.
NCT04068844 is a NA study of Heart Failure, Diastolic that is active but no longer recruiting, run by University of Texas Southwestern Medical Center. The registered enrollment target is 93 participants, below the 314-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04068844, a NA study of Heart Failure, Diastolic, is active but no longer recruiting, sponsored by University of Texas Southwestern Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
- 1
- Study location
Study Summary
The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.
Primary Outcome
Change in peak VO2 after exercise training
Conditions Studied
Interventions
- BEHAVIORAL Exercise training
Study Locations (1)
Texas
- The Institute for Exercise and Environmental Medicine - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2019-08-01 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What the registry record for NCT04068844 still lists
NCT04068844 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 93 participants, a relatively small participant target, below the 314-participant average among 14 other Heart Failure, Diastolic trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Heart Failure, Diastolic appearing as the primary indexed condition, and to 1 intervention - of which Exercise training is the first listed.
NCT04068844 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04068844 about?
NCT04068844 is a clinical study titled "Mechanisms of Exercise Intolerance in Heart Failure With Preserved Ejection Fraction". The global objective of this study is to determine the mechanisms of exercise intolerance and dyspnea on exertion (DOE) in patients with HFpEF and based on this pathophysiology, test whether specific exercise training programs (whole body vs single leg) will result in improved exercise tolerance.
What is the current status of trial NCT04068844?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 93 participants. The study started on 2019-08-01. Estimated completion is 2025-12-31.
What conditions does trial NCT04068844 study?
This clinical trial studies the following conditions: Heart Failure, Diastolic.
What interventions are being tested in trial NCT04068844?
The interventions under investigation include: Exercise training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04068844?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04068844 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure, Diastolic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04068844's enrollment target sits among peer trials
93 6th of 14 higher than 9 of 14 other Heart Failure, Diastolic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure, Diastolic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
Pilot Study Lp299v Supplementation in Chronic Heart Failure
RECRUITING · NA
-
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
RECRUITING · NA
-
RESPONDER-HF Trial
ACTIVE NOT RECRUITING · NA
-
Improving Metabolic Health in Patients With Diastolic Dysfunction
COMPLETED · NA
-
Exercise Intolerance in Elderly Patients With Diastolic Heart Failure
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02203526 · 93 participants · Phase 1
Phase 1 Study of Ibrutinib and Immuno-Chemotherapy Using Temozolomide, Etoposide, Doxil, Dexamethasone, Ibrutinib,Rituximab (TEDDI-R) in Primary CNS Lymphoma
- NCT03089554 · 93 participants · Phase 2
Evaluating Genomic Testing in Human Cancer & Outcomes of Targeted Therapies
- NCT05000021 · 93 participants · NA
Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes
- NCT05489887 · 93 participants · Phase 2
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI